Skip to main content

Hypoxemia

1
Pipeline Programs
8
Companies
9
Clinical Trials
3 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

8 companies ranked by most advanced pipeline stage

Allergy Therapeutics
Allergy TherapeuticsUK - West Sussex
1 program
1
CorticosteroidPhase 41 trial
Active Trials
NCT07199192Not Yet Recruiting3,000Est. Dec 2028
Medtronic
MedtronicNJ - Phillipsburg
2 programs
CapnographyN/A1 trial
Oxygen Saturation Alarms in the Neonatal Intensive Care UnitN/A1 trial
Active Trials
NCT01949012Completed190Est. Jun 2015
NCT01085539Completed50Est. Jun 2010
Colorado Therapeutics
Colorado TherapeuticsCO - Louisville
1 program
Continuous positive airway pressureN/A1 trial
Active Trials
NCT05971290Unknown25Est. Oct 2023
UNION therapeutics
UNION therapeuticsDenmark - Hellerup
1 program
Driving pressure-guided positive end expiratory pressureN/A1 trial
Active Trials
NCT06361420Recruiting43Est. Dec 2025
Oregon Therapeutics
Oregon TherapeuticsFrance - Paris
1 program
Oxygen administrationN/A1 trial
Active Trials
NCT02523586Completed14Est. Jun 2016
City Therapeutics
City TherapeuticsMA - Cambridge
1 program
Procedural Oxygen MaskN/A1 trial
Active Trials
NCT07234188RecruitingEst. May 2026
Nihon Kohden
Nihon KohdenNEW YORK, NY
1 program
Pulse oximeterN/A1 trial
Active Trials
NCT07168798Enrolling By Invitation180Est. Nov 2028
Masimo
MasimoIRVINE, CA
1 program
RD SET SensorN/A1 trial
Active Trials
NCT06432881Recruiting152Est. May 2026

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
Allergy TherapeuticsCorticosteroid
City TherapeuticsProcedural Oxygen Mask
Nihon KohdenPulse oximeter
UNION therapeuticsDriving pressure-guided positive end expiratory pressure
MasimoRD SET Sensor
Colorado TherapeuticsContinuous positive airway pressure
Oregon TherapeuticsOxygen administration
MedtronicCapnography
MedtronicOxygen Saturation Alarms in the Neonatal Intensive Care Unit

Clinical Trials (9)

Total enrollment: 3,654 patients across 9 trials

NCT07199192Allergy TherapeuticsCorticosteroid

Steroid Treatment for Severe Acute Respiratory Infection (STAR) Trial

Start: Mar 2026Est. completion: Dec 20283,000 patients
Phase 4Not Yet Recruiting
NCT07234188City TherapeuticsProcedural Oxygen Mask

POM vs HFNC for Hypoxemia Prevention in Children

Start: Mar 2026Est. completion: May 2026
N/ARecruiting
NCT07168798Nihon KohdenPulse oximeter

SpO2 Accuracy in Children

Start: Nov 2025Est. completion: Nov 2028180 patients
N/AEnrolling By Invitation
NCT06361420UNION therapeuticsDriving pressure-guided positive end expiratory pressure

Driving Pressure-guided Lung Protective Ventilation

Start: Jan 2024Est. completion: Dec 202543 patients
N/ARecruiting
NCT06432881MasimoRD SET Sensor

Investigation of Skin Pigmentation Effect on Performance of Masimo Pulse Oximetry (INSPIRE)

Start: Jan 2024Est. completion: May 2026152 patients
N/ARecruiting
NCT05971290Colorado TherapeuticsContinuous positive airway pressure

Effects of Continuous Positive Airway Pressure on Peripheral Oxygen Saturation, Work of Breathing, and Exercise Tolerance at Altitude

Start: Jul 2023Est. completion: Oct 202325 patients
N/AUnknown
NCT02523586Oregon TherapeuticsOxygen administration

Comparison of Pharyngeal Oxygen Delivery by Different Oxygen Masks

Start: May 2015Est. completion: Jun 201614 patients
N/ACompleted
NCT01949012MedtronicCapnography

Capnography Monitoring During Intravenous Conscious Sedation Sedation With Midazolam for Oral Surgery

Start: Oct 2013Est. completion: Jun 2015190 patients
N/ACompleted
NCT01085539MedtronicOxygen Saturation Alarms in the Neonatal Intensive Care Unit

Oxygen Saturation Alarms in the Neonatal Intensive Care Unit

Start: Jan 2010Est. completion: Jun 201050 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

3 actively recruiting trials targeting 3,654 patients
8 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.